The Analgesic and Antineuroinflammatory Effect of Baicalein in Cancer-Induced Bone Pain

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Hu, Shan ^a   Chen, Yu ^b   Wang, Zhi Fu ^c   Mao Ying, Qi Liang ^a   Mi, Wen Li ^a   Jiang, Jian Wei ^a   Wu, Gen Cheng ^a   Wang, Yan Qing ^a  

^a FUDAN UNIVERSITY   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

^c FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BAICALEIN; CYTOKINE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE PAIN; CANCER INDUCED BONE PAIN; CANCER PAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INHIBITION; ENZYME ACTIVATION; FEMALE; HIND PAW; INFLAMMATION; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 84948845357     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/973524     Document Type: Article

References (49)

1. R. Rizzoli, J.-J. Body, M.-L. Brandi et al., "Cancer-associated bone disease," Osteoporosis International, vol. 24, no. 12, pp. 2929-2953, 2013.
2. Y. Zhang, B. Ma, and Q. Fan, "Mechanisms of breast cancerbone metastasis," Cancer Letters, vol. 292, no. 1, pp. 1-7, 2010.
3. P. D. De Ciantis, K. Yashpal, J. Henry, and G. Singh, "Characterization of a rat model of metastatic prostate cancer bone pain," Journal of Pain Research, vol. 3, pp. 213-221, 2010.
4. P. W. Mantyh, "A mechanism based understanding of cancer pain," Pain, vol. 96, no. 1-2, pp. 1-2, 2002.
5. M. J. Schwei, P. Honore, S. D. Rogers et al., "Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain," Journal of Neuroscience, vol. 19, no. 24, pp. 10886-10897, 1999.
6. S. J. Medhurst, K. Walker, M. Bowes et al., "A rat model of bone cancer pain," Pain, vol. 96, no. 1-2, pp. 129-140, 2002.
7. Q.-L. Mao-Ying, J. Zhao, Z.-Q. Dong et al., "A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells," Biochemical and Biophysical Research Communications, vol. 345, no. 4, pp. 1292-1298, 2006.
8. S. Falk and A. H. Dickenson, "Pain and nociception: mechanisms of cancer-induced bone pain," Journal of Clinical Oncology, vol. 32, no. 16, pp. 1647-1654, 2014.
9. A. N. Lozano-Ondoua, A. M. Symons-Liguori, and T. W. Vanderah, "Cancer-induced bone pain: mechanisms and models," Neuroscience Letters, vol. 557, part A, pp. 52-59, 2013.
10. Q.-L. Mao-Ying, X.-W. Wang, C.-J. Yang et al., "Robust spinal neuroinflammation mediates mechanical allodynia in Walker 256 induced bone cancer rats," Molecular Brain, vol. 5, article 16, 2012.
11. C. Nathan and A. Ding, "Nonresolving inflammation," Cell, vol. 140, no. 6, pp. 871-882, 2010.
12. L. S. Lan, Y. J. Ping, W. L. Na et al., "Down-regulation of Toll-like receptor 4 gene expression by short interfering RNA attenuates bone cancer pain in a rat model," Molecular Pain, vol. 6, article 2, 2010.
13. W. Lee, S.-K. Ku, and J.-S. Bae, "Anti-inflammatory effects of baicalin, baicalein, and wogonin in vitro and in vivo," Inflammation, vol. 38, no. 1, pp. 110-125, 2015.
14. M. Li-Weber, "New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin," Cancer Treatment Reviews, vol. 35, no. 1, pp. 57-68, 2009.
15. Z. Tayarani-Najaran, S. A. Emami, J. Asili, A. Mirzaei, and S. H. Mousavi, "Analyzing cytotoxic and apoptogenic properties of scutellaria litwinowii root extract on cancer cell lines," Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 160682, 9 pages, 2011.
16. E. Lee, H. R. Park, S. T. Ji, Y. Lee, and J. Lee, "Baicalein attenuates astroglial activation in the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson's disease model by downregulating the activations of nuclear factor-κB, ERK, and JNK," Journal of Neuroscience Research, vol. 92, no. 1, pp. 130-139, 2014.
17. S. Qin, F. Deng, W. Wu et al., "Baicalein modulates Nrf2/Keap1 systemin both Keap1-dependent and Keap1-independen tmechanisms," Archives of Biochemistry and Biophysics, vol. 559, pp. 53-61, 2014.
18. X. Xue, H. Liu, L. Qi et al., "Baicalein ameliorated the upregulation of striatal glutamatergic transmission in the mice model of Parkinson's disease," Brain Research Bulletin, vol. 103, pp. 54-59, 2014.
19. P. Sithisarn, M. Michaelis, M. Schubert-Zsilavecz, and J. J. Cinatl, "Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells," Antiviral Research, vol. 97, no. 1, pp. 41-48, 2013.
20. B. P. Gaire, S.-K. Moon, and H. Kim, "Scutellaria baicalensis in stroke management: nature's blessing in traditional Eastern medicine," Chinese Journal of Integrative Medicine, vol. 20, no. 9, pp. 712-720, 2014.
21. G. A. Czapski, K. Czubowicz, and R. P. Strosznajder, "Evaluation of the antioxidative properties of lipoxygenase inhibitors," Pharmacological Reports, vol. 64, no. 5, pp. 1179-1188, 2012.
22. J. D. Deschamps, V. A. Kenyon, and T. R. Holman, "Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases," Bioorganic and Medicinal Chemistry, vol. 14, no. 12, pp. 4295-4301, 2006.
23. S. Hu, Q.-L. Mao-Ying, J. Wang et al., "Lipoxins and aspirintriggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines," Journal of Neuroinflammation, vol. 9, article 278, 2012.
24. E. Ganon-Elazar and I. Akirav, "Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit," Psychoneuroendocrinology, vol. 38, no. 9, pp. 1675-1687, 2013.
25. J. J. Xu, B. C. Walla, M. F. Diaz, G. N. Fuller, and H. B. Gutstein, "Intermittent lumbar puncture in rats: a novel method for the experimental study of opioid tolerance," Anesthesia and Analgesia, vol. 103, no. 3, pp. 714-720, 2006.
26. S. Sun, H. Cao, M. Han, T. T. Li, Z. Q. Zhao, and Y. Q. Zhang, "Evidence for suppression of electroacupuncture on spinal glial activation and behavioral hypersensitivity in a rat model of monoarthritis," Brain Research Bulletin, vol. 75, no. 1, pp. 83-93, 2008.
27. J. Wang, J. Li, X. Sheng et al., "β-adrenoceptor mediated surgery-induced production of pro-inflammatory cytokines in rat microglia cells," Journal of Neuroimmunology, vol. 223, no. 1-2, pp. 77-83, 2010.
28. X.-W. Wang, S. Hu, Q.-L. Mao-Ying et al., "Activation of c-jun N-terminal kinase in spinal cord contributes to breast cancer induced bone pain in rats," Molecular Brain, vol. 5, article 21, 2012.
29. G. Germano, P. Allavena, and A. Mantovani, "Cytokines as a key component of cancer-related inflammation," Cytokine, vol. 43, no. 3, pp. 374-379, 2008.
30. A. L. Pritchard and N. K. Hayward, "Molecular pathways: mitogen-activated protein kinase pathway mutations and drug resistance," Clinical Cancer Research, vol. 19, no. 9, pp. 2301-2309, 2013.
31. D. Sukhtankar, A. Okun, A. Chandramouli et al., "Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in amurine model of cancerinduced bone pain," Molecular Pain, vol. 7, article 81, 2011.
32. X.-W. Wang, T.-T. Li, J. Zhao et al., "Extracellular signalregulated kinase activation in spinal astrocytes and microglia contributes to cancer-induced bone pain in rats," Neuroscience, vol. 217, pp. 172-181, 2012.
33. B. A. Croker, H. Kiu, and S. E. Nicholson, "SOCS regulation of the JAK/STAT signalling pathway," Seminars in Cell & Developmental Biology, vol. 19, no. 4, pp. 414-422, 2008.
34. H. Yu, H. Lee, A. Herrmann, R. Buettner, and R. Jove, "Revisiting STAT3 signalling in cancer: new and unexpected biological functions," Nature Reviews Cancer, vol. 14, no. 11, pp. 736-746, 2014.
35. M. Tsuda, Y. Kohro, T. Yano et al., "JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats," Brain, vol. 134, no. 4, pp. 1127-1139, 2011.
36. E. Dominguez, A. Mauborgne, J. Mallet, M. Desclaux, and M. Pohl, "SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury," Journal of Neuroscience, vol. 30, no. 16, pp. 5754-5766, 2010.
37. J. Candido and T. Hagemann, "Cancer-related inflammation," Journal of Clinical Immunology, vol. 33, supplement 1, pp. S79-S84, 2013.
38. K. Zandi, B.-T. Teoh, S.-S. Sam, P.-F. Wong, M. R. Mustafa, and S. AbuBakar, "Novel antiviral activity of baicalein against dengue virus," BMC Complementary and Alternative Medicine, vol. 12, article 214, 2012.
39. W. Lam, S. Bussom, F. Guan et al., "The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity," Science Translational Medicine, vol. 2, no. 45, pp. 45r-59r, 2010.
40. 3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 17, pp. 6721-6726, 2012.
41. P. Honore, S. D. Rogers, M. J. Schwei et al., "Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons," Neuroscience, vol. 98, no. 3, pp. 585-598, 2000.
42. Y.-W. Xu, L. Sun, H. Liang, G.-M. Sun, and Y. Cheng, "12/15-lipoxygenase inhibitor baicalein suppresses PPARγ expression and nuclear translocation induced by cerebral ischemia/reperfusion," Brain Research, vol. 1307, pp. 149-157, 2010.
43. X.-M. Xu, G.-J. Yuan, J.-J. Deng et al., "Inhibition of 12-lipoxygenase reduces proliferation and induces apoptosis of hepatocellular carcinoma cells in vitro and in vivo," Hepatobiliary and Pancreatic Diseases International, vol. 11, no. 2, pp. 193-202, 2012.
44. Y. Gao, J. Lu, Y. Zhang, Y. Chen, Z. Gu, and X. Jiang, "Baicalein attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of miR-21," Pulmonary Pharmacology & Therapeutics, vol. 26, no. 6, pp. 649-654, 2013.
45. R.-R. Ji, T. A. Samad, S.-X. Jin, R. Schmoll, and C. J. Woolf, "p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia," Neuron, vol. 36, no. 1, pp. 57-68, 2002.
46. K. Obata, H. Katsura, T. Mizushima et al., "TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury," Journal of Clinical Investigation, vol. 115, no. 9, pp. 2393-2401, 2005.
47. Y.-J. Gao and R.-R. Ji, "Activation of JNK pathway in persistent pain," Neuroscience Letters, vol. 437, no. 3, pp. 180-183, 2008.
48. Y.-J. Gao, Z.-Z. Xu, Y.-C. Liu, Y.-R. Wen, I. Decosterd, and R.-R. Ji, "The c-Jun N-terminal kinase 1 (JNK1) in spinal astrocytes is required for the maintenance of bilateral mechanical allodynia under a persistent inflammatory pain condition," Pain, vol. 148, no. 2, pp. 309-319, 2010.
49. I. L. Campbell, "Cytokine-mediated inflammation, tumorigenesis, and disease-associated JAK/STAT/SOCS signaling circuits in the CNS," Brain Research Reviews, vol. 48, no. 2, pp. 166-177, 2005.